Estados financieros detallados de CNS Pharmaceuticals, Inc. (CNSP): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $5.50, CNSP presenta beneficios negativos (P/E no significativo) y un ROE del -204.25%. La capitalización bursátil es de $8M.
Cuenta de Resultados (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | 0 | 0 | $1955 | $11096 | $13070 | $11756 | $4134 | $3306 | 0 |
| Beneficio Bruto | 0 | 0 | -$1955 | -$11096 | -$13070 | -$11756 | -$4134 | -$3306 | 0 |
| I+D | $32638 | $21267 | $1.9M | $5.1M | $9.8M | $9.3M | $14.1M | $9.3M | $9.8M |
| Generales y Administrativos | $182467 | $860520 | $2.0M | $4.4M | $4.7M | $5.6M | $4.8M | $5.6M | $6.2M |
| Gastos Operativos | $215105 | $881787 | $3.8M | $9.4M | $14.5M | $14.9M | $18.9M | $14.9M | $16.0M |
| Beneficio Operativo | -$516252 | -$881787 | -$3.8M | -$9.5M | -$14.5M | -$14.9M | -$18.9M | -$14.9M | -$16.0M |
| EBITDA | 0 | -$6.5M | -$3.8M | -$9.4M | -$14.5M | -$15.3M | -$18.8M | -$14.8M | -$15.8M |
| Gastos por Intereses | $4257 | $46697 | $44234 | $3264 | $9285 | $7027 | $13805 | $16119 | $15230 |
| Beneficio Antes de Impuestos | -$219362 | -$7.4M | -$3.9M | -$9.5M | -$14.5M | -$15.3M | -$18.9M | -$14.9M | -$15.9M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$526469 | -$7.4M | -$3.9M | -$9.5M | -$14.5M | -$15.3M | -$18.9M | -$14.9M | -$15.9M |
| BPA | $-11997.00 | $-404415.00 | $-212121.00 | $-512208.00 | $-495027.00 | $-336499.00 | $-150114.00 | $-466.44 | $-35.75 |
| BPA Diluido | $-11997.00 | $-404415.00 | $-212121.00 | $-512208.00 | $-495027.00 | $-336499.00 | $-150114.00 | $-466.44 | $-35.75 |
| Acciones en Circulación (Diluidas) | $18 | $18 | $18 | $18 | $29 | $45 | $126 | $31853 | $443369 |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | 0 | 0 | 0 | 0 |
| Beneficio Bruto | -$697 | $2898 | -$1868 | 0 |
| Beneficio Operativo | -$3.3M | -$6.0M | -$5.0M | -$2.7M |
| EBITDA | -$3.2M | -$6.0M | -$4.9M | -$2.6M |
| Beneficio Neto | -$3.2M | -$6.0M | -$4.9M | -$2.6M |
| BPA | $-5.76 | $-10.15 | $-7.30 | $-0.38 |
| BPA Diluido | $-5.76 | $-10.15 | $-7.30 | $-0.38 |
Balance (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $110543 | $282736 | $7.2M | $14.0M | $5.0M | $10.1M | $548721 | $6.5M | $7.2M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $882539 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $162194 | $588133 | $7.9M | $15.5M | $7.5M | $12.6M | $1.6M | $8.7M | $8.1M |
| Inmovilizado Material | 0 | 0 | $18165 | $23431 | $16109 | $5664 | $4933 | $6005 | $17703 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $162194 | $683333 | $7.9M | $15.9M | $8.8M | $13.1M | $1.7M | $8.7M | $8.6M |
| Cuentas por Pagar | $57497 | $128865 | $289499 | $946330 | $1.5M | $3.7M | $5.8M | $2.2M | $3.8M |
| Deuda a Corto | $121825 | $316918 | 0 | $439294 | $387794 | $409968 | $300806 | $326072 | $328571 |
| Pasivos Corrientes | $220726 | $1.2M | $311000 | $1.9M | $2.1M | $4.9M | $6.1M | $2.5M | $4.1M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $220726 | $1.2M | $311000 | $1.9M | $2.1M | $4.9M | $6.1M | $2.5M | $4.1M |
| Reservas | -$219362 | -$7.6M | -$11.5M | -$20.9M | -$35.0M | -$50.7M | -$69.6M | -$84.4M | -$100.3M |
| Patrimonio Neto | -$58532 | -$549298 | $7.6M | $13.9M | $6.6M | $8.1M | -$4.4M | $6.2M | $4.5M |
| Deuda Total | $121825 | $316918 | 0 | $439294 | $387794 | $409968 | $300806 | $326072 | $328571 |
| Deuda Neta | $11282 | $34182 | -$7.2M | -$13.6M | -$4.6M | -$9.6M | -$247915 | -$6.1M | -$6.9M |
| Capital Circulante | -$58532 | -$644498 | $7.6M | $13.6M | $5.3M | $7.6M | -$4.5M | $6.1M | $4.0M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $9.9M | $7.2M | $3.0M | $20.0M |
| Activos Totales | $11.9M | $8.6M | $4.7M | $21.9M |
| Pasivos Totales | $2.0M | $4.1M | $4.6M | $3.7M |
| Patrimonio Neto | $9.9M | $4.5M | $70705 | $18.2M |
| Deuda Total | $30793 | $328571 | $232353 | 0 |
Flujo de Caja (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$219362 | -$7.4M | -$3.9M | -$9.5M | -$14.5M | -$15.3M | -$18.9M | -$14.9M | -$15.9M |
| Amortizaciones | $2342 | 0 | $1955 | $11096 | $13070 | $11756 | $4134 | $3306 | $3918 |
| Compensación en Acciones | $119854 | $110240 | $477096 | $1.3M | $1.7M | $1.2M | $1.0M | $838957 | $187728 |
| Cambio en Capital Circulante | $47250 | $83777 | -$425619 | $833782 | -$780021 | $3.2M | $3.7M | -$3.7M | $1.8M |
| Flujo de Caja Operativo | -$112197 | -$716385 | -$3.6M | -$7.3M | -$13.5M | -$10.6M | -$14.1M | -$17.1M | -$13.8M |
| Inversiones (CapEx) | -$3 | $5 | -$20120 | -$17945 | -$5748 | -$4422 | -$3901 | -$4188 | -$18175 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -$2043 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$112197 | -$716385 | -$3.6M | -$7.3M | -$13.5M | -$10.6M | -$14.1M | -$17.1M | -$13.8M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$2.2M | -$3.1M | -$4.6M | -$3.5M |
| Inversiones (CapEx) | 0 | -$18175 | -$6179 | -$3821 |
| Flujo de Caja Libre | -$2.2M | -$3.1M | -$4.7M | -$3.5M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $18452 | $85068 | $2555 | $2445 |
Crecimiento y Márgenes (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Beneficio Neto (anual) | | -1304.1% | +47.5% | -143.9% | -53.3% | -5.4% | -23.4% | +21.2% | -6.7% |
| Crecimiento BPA (anual) | | -3271.0% | +47.5% | -141.5% | +3.4% | +32.0% | +55.4% | +99.7% | +92.3% |
| Cambio en Acciones (anual) | | +0.0% | +0.0% | +1.0% | +58.6% | +55.0% | +176.7% | +25264.9% | +1291.9% |
| Crecimiento FCF (anual) | | -538.5% | -398.8% | -105.3% | -84.6% | +22.0% | -33.9% | -21.0% | +19.2% |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-6138.35 | $-39193.76 | $-195512.89 | $-397291.58 | $-462542.98 | $-232693.33 | $-112629.70 | $-537.39 | $-31.19 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $18 | $18 | $18 | $18 | $29 | $45 | $126 | $31853 | $443369 |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -204.25% |
| Rentabilidad sobre capital invertido | -92.94% |
| Rentabilidad sobre activos | -76.12% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 5.86 |
| Piotroski F-Score | 1 |
| Altman Z-Score | -21.50 |
Ratios Clave (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -342.84 | -10.17 | -16.76 | -3.13 | -1.28 | -0.21 | -0.25 | -0.15 | -0.15 |
| P/VC | -1284.38 | -136.86 | 8.55 | 2.12 | 2.80 | 0.40 | -1.08 | 0.37 | 0.51 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |